This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...